A lawmaker compared getting the vaccine with using meth. The Idaho Medical Association said his bill would infringe on ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid ...

By Puyaan Singh March 4 (Reuters) - Moderna shares rose 9% on Wednesday after it settled a long-running legal battle over the ...

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...

Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.

Moderna Inc.’s settlement to end a lawsuit over technology used in its Covid-19 vaccine caps its potential exposure at $2.25 ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in ...

Moderna jumps 4% after EU panel backs mCombriax, its COVID-19-flu combo shot, with phase III data showing stronger immune ...

CHMP adopts positive opinion on Moderna’s mRNA combination vaccine ‘mCOMBRIAX’ against influenza, Covid-19: Cambridge, Massachusetts Wednesday, March 4, 2026, 16:00 Hrs [IST ...

EMA backs Moderna’s dual COVID-19 and flu vaccine, mCombriax, paving the way for EU approval ahead of the 2026–2027 season.

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

COVID-19 vaccines are back under review by the CDC, and the move is raising concern among some health experts.